IRC
RBOT

Investors Research Corp’s Vicarious Surgical RBOT Stock Holding History

Investors Research Corp’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$30 – 1152
2022
Q4 		$30 Hold
1
– – ﹤0.01% 1131
2022
Q3 		$0 Hold
1
– – ﹤0.01% 1125
2022
Q2 		$0 Hold
1
– – ﹤0.01% 1139
2022
Q1 		$0 Hold
1
– – ﹤0.01% 1082
2021
Q4 		$0 Hold
1
– – ﹤0.01% 1033
2021
Q3 		$0 Hold
1
– – ﹤0.01% 1028
2021
Q2 		$0 Buy
+1
New +$298 ﹤0.01% 1009

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DP
DDD Partners Bellevue, Washington $1.45B AUM 9.14% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
HVCM
Hel Ved Capital Management Central, Hong Kong $844M AUM 191.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Investors Research Corp's RBOT Position: Q1 2023 in Review

Investors Research Corp sold out of Vicarious Surgical (RBOT) in Q1 2023, closing a stake of 1 share — an estimated $30 sold.

Investors Research Corp first reported a position in RBOT in Q2 2021 and held it in 7 quarters. The position peaked at $30 in Q4 2022. 79 funds tracked by Wall St. Rank hold RBOT as of Q1 2023.

  • Investors Research Corp reported no remaining Vicarious Surgical position as of Q1 2023 after selling out during the quarter.
  • Investors Research Corp sold 1 Vicarious Surgical share in Q1 2023, an estimated $30.
  • Investors Research Corp first reported a position in Vicarious Surgical in Q2 2021 and held it in 7 quarters.
  • Investors Research Corp's Vicarious Surgical position peaked at $30 in Q4 2022.
  • 79 funds tracked by Wall St. Rank held Vicarious Surgical as of Q1 2023.

Based on Investors Research Corp's 13F filing for Q1 2023, filed 11 May 2023.